PMA device
LCS® Total Knee System
Depuy, Inc. · Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Metal/Polymer, Mobile Bearing (NJL, Class III) · First FDA decision Mar 6, 2000, newest Mar 15, 2024Knee osteoarthritis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
27
PMA pathway
Device trials
22
Naming "LCS"
MAUDE reports
2,421
Brand "LCS", since 2015
PubMed studies
7,112
Mentioning "LCS"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing LCS® Total Knee System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 27 decisions filed under this name.
- LCS® Total Knee SystemPMA supplement
P830055-S313 · Decided Mar 15, 2024 · 197 days after receipt · Normal 180 Day Track No User Fee
Device type: Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing (NJL) · Orthopedic Surgery
- LCS® Total Knee SystemPMA supplement
P830055-S311 · Decided Feb 27, 2024 · 207 days after receipt · Normal 180 Day Track No User Fee
Device type: Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing (NJL) · Orthopedic Surgery
- LCS® Total Knee SystemPMA supplement
P830055-S310 · Decided Dec 19, 2023 · 174 days after receipt · Normal 180 Day Track No User Fee
Device type: Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing (NJL) · Orthopedic Surgery
3 more FDA decisions with a free account
Older decisions: P830055-S270, P830055-S265, P830055-S261, P830055-S257, P830055-S226, P830055-S215, P830055-S211, P830055-S210, P830055-S179, P830055-S150, P830055-S144, P830055-S134, P830055-S116, P830055-S107, P830055-S106, P830055-S085, P830055-S082, P830055-S080, P830055-S075, P830055-S070, P830055-S068
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "LCS", any status and sponsor, newest update first.
DePuy InternationalPublic (JNJ)
NCT00733915 · 241 participants · Start Mar 1, 2002 · Primary completion Sep 1, 2007
Device: L.C.S. Complete Knee (DePuy Low Contact Stress Complete Knee System) · For: Arthroplasty, Replacement, Knee
Sites: Belfast, Ireland
Median TechnologiesNot on our public-company list
NCT06751576 · 480 participants · Start Sep 21, 2022 · Primary completion Jan 31, 2025
Device: Median LCS · For: High Risk Cancer; Lung Cancer
Sites: Philadelphia, Pennsylvania; Memphis, Tennessee; Houston, Texas · 5 sites in all
DePuy InternationalPublic (JNJ)
NCT00733694 · 607 participants · Start Apr 1, 2000 · Primary completion Apr 1, 2008
Device: LCS® Complete™ Mobile Bearing Knee Systems · For: Knee Osteoarthritis
Sites: Hong Kong, China
19 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "LCS", and for the whole product code for context.
This brand
2,421 reports: 300 malfunction, 2,120 injury, 1 death
Whole product code NJL
18,323 reports: 772 malfunction, 17,543 injury, 7 death
Newest reports for this brand
- LCS COMPLETE POROCOATInjury
1818910-2026-18682 · Received Oct 27, 2026 · Event dated Oct 9, 2026
Device type: Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Metal/Polymer, Mobile Bearing (NJL)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Unspecified Infection
- Sigma LCS CompleteInjury
1818910-2026-18684 · Received Oct 27, 2026 · Event dated Oct 9, 2026
Device type: Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Metal/Polymer, Mobile Bearing (NJL)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Unspecified Infection
- LCS COMPLETEInjury
1818910-2026-18685 · Received Oct 27, 2026 · Event dated Oct 9, 2026
Device type: Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Metal/Polymer, Mobile Bearing (NJL)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Unspecified Infection
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2394-2021 · Started Aug 10, 2021
Reason given: Software: A coding error associated with the Fast3D Segmentation software. During the scanning process the three images required of the hip, knee and ankle may not be aligned, causing the anatomic landmark locations to potentially result in limb malalignment.
Cause as FDA categorized it: Software Design Change · Device type: Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Metal/Polymer, Mobile Bearing (NJL)
Z-2395-2021 · Started Aug 10, 2021
Reason given: Software: A coding error associated with the Fast3D Segmentation software. During the scanning process the three images required of the hip, knee and ankle may not be aligned, causing the anatomic landmark locations to potentially result in limb malalignment.
Cause as FDA categorized it: Software Design Change · Device type: Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Metal/Polymer, Mobile Bearing (NJL)
Z-2396-2021 · Started Aug 10, 2021
Reason given: Software: A coding error associated with the Fast3D Segmentation software. During the scanning process the three images required of the hip, knee and ankle may not be aligned, causing the anatomic landmark locations to potentially result in limb malalignment.
Cause as FDA categorized it: Software Design Change · Device type: Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Metal/Polymer, Mobile Bearing (NJL)
7 more recall records with a free account
Published research
The most relevant PubMed records for "LCS"[tiab]. The summary above synthesizes these.
- Potential Effects of Low-Calorie Sweeteners on Human Health.
Chen HP, Kao Y, Lin MW, et al. · Nutrients · 2025Review
- Gradient-Based Local Causal Structure Learning.
Liang J, Wang J, Yu G, et al. · IEEE Trans Cybern · 2024
- Langerhans cells and skin immune diseases.
Zhu R, Yao X, Li W · Eur J Immunol · 2024Review
- An extracellular vesicle-mediated mitochondrial transfer network critical for testosterone synthesis.
Xia K, Zhang S, Peng H, et al. · Nat Cell Biol · 2026
- Milestones towards lung cancer screening implementation.
Silva M, Milanese G, Kauczor HU, et al. · Clin Radiol · 2020Editorial
- Low Calorie Sweetener (LCS) use and energy balance.
Peters JC, Beck J · Physiol Behav · 2016Review
- Lung cancer screening: where do we stand?
Hardavella G, Frille A, Sreter KB, et al. · Breathe (Sheff) · 2024Review
- Trends in the consumption of low-calorie sweeteners.
Sylvetsky AC, Rother KI · Physiol Behav · 2016Review, Research Support, N.I.H., Intramural
- The radiologist's role in lung cancer screening.
Snoeckx A, Franck C, Silva M, et al. · Transl Lung Cancer Res · 2021Review
- Langerhans Cells-Revising Their Role in Skin Pathologies.
Neagu M, Constantin C, Jugulete G, et al. · J Pers Med · 2022Review
- Vaginal bacterium Prevotella timonensis turns protective Langerhans cells into HIV-1 reservoirs for virus dissemination.
van Teijlingen NH, Helgers LC, Sarrami-Forooshani R, et al. · EMBO J · 2022Research Support, Non-U.S. Gov't
- Immunolocalization of CD1a expressing dendritic cells in sinonasal polyposis.
Jayasekhar R, Mathew JKK, Sangi Z, et al. · J Immunoassay Immunochem · 2022
Other devices of this type
Also filed under product code NJL.
- Zimmer Nexgen Lps-Flex Mobile and Lps-Mobile Bearing Knee SystemZimmer, Inc. · PMA 2016
- Attune Revision Knee SystemDepuy, Inc. · PMA 2026
- ATTUNE Revision Rotating Platform (RP) Knee SystemDepuy, Inc. · PMA 2025
- ATTUNETM Rotating Platform (RP) Total Knee SystemDepuy, Inc. · PMA 2025
- Attune Primary SystemDepuy, Inc. · PMA 2025
- NexGen LPS-Flex/LPS Mobile Bearing Knee SystemZimmer, Inc. · PMA 2021
- Lsc Total Knee SystemDepuy, Inc. · PMA 2013
- Flex Mobile Bearing KneeZimmer, Inc. · PMA 2011
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.